Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission

Guardado en:

Detalles Bibliográficos
Autores principales:	Richard Carvajal, Shaheer Khan, Tejus Satish, Matt Levin, Angela J Yoon
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/2806a1c1044342f6a2b86e88ba34f72b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2806a1c1044342f6a2b86e88ba34f72b
record_format	dspace
spelling	oai:doaj.org-article:2806a1c1044342f6a2b86e88ba34f72b2021-12-04T14:00:06ZTreatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission10.1136/jitc-2020-0012192051-1426https://doaj.org/article/2806a1c1044342f6a2b86e88ba34f72b2021-10-01T00:00:00Zhttps://jitc.bmj.com/content/9/10/e001219.fullhttps://doaj.org/toc/2051-1426Richard CarvajalShaheer KhanTejus SatishMatt LevinAngela J YoonBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Richard Carvajal Shaheer Khan Tejus Satish Matt Levin Angela J Yoon Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission
format	article
author	Richard Carvajal Shaheer Khan Tejus Satish Matt Levin Angela J Yoon
author_facet	Richard Carvajal Shaheer Khan Tejus Satish Matt Levin Angela J Yoon
author_sort	Richard Carvajal
title	Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission
title_short	Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission
title_full	Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission
title_fullStr	Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission
title_full_unstemmed	Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission
title_sort	treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission
publisher	BMJ Publishing Group
publishDate	2021
url	https://doaj.org/article/2806a1c1044342f6a2b86e88ba34f72b
work_keys_str_mv	AT richardcarvajal treatmentofrecurrentmucosalmelanomaoftheoralcavitywithtopicalimiquimodandpembrolizumabachievescompletehistopathologicremission AT shaheerkhan treatmentofrecurrentmucosalmelanomaoftheoralcavitywithtopicalimiquimodandpembrolizumabachievescompletehistopathologicremission AT tejussatish treatmentofrecurrentmucosalmelanomaoftheoralcavitywithtopicalimiquimodandpembrolizumabachievescompletehistopathologicremission AT mattlevin treatmentofrecurrentmucosalmelanomaoftheoralcavitywithtopicalimiquimodandpembrolizumabachievescompletehistopathologicremission AT angelajyoon treatmentofrecurrentmucosalmelanomaoftheoralcavitywithtopicalimiquimodandpembrolizumabachievescompletehistopathologicremission
_version_	1718372782407942144

Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission

Ejemplares similares